Does insurance cover Wegovy?
Wegovy is FDA-approved specifically for chronic weight management, but health plan coverage for weight-loss drugs is inconsistent — many plans exclude them entirely while a growing number cover them with prior authorization and BMI-based criteria.
What flips the answer
- Covered when
The employer or marketplace plan specifically includes a weight-management drug benefit and prior authorization criteria (BMI, comorbidity) are met.
- Not covered when
The plan carries a blanket exclusion for weight-loss medications, which remains common.
- Not covered when
A prior-authorization renewal is denied because demonstrated weight-loss progress didn't meet the plan's threshold, or the employer drops the benefit at the next plan year.
Wegovy (semaglutide) is FDA-approved for chronic weight management in adults with obesity or overweight plus a weight-related condition, unlike Ozempic, which is approved for type 2 diabetes. That distinction matters for coverage, because many health plans historically excluded medications prescribed specifically for weight loss.
Employer plans and marketplace plans differ widely on this. Some formularies cover Wegovy with prior authorization requiring a minimum BMI, documentation of a weight-related condition, and proof of prior diet or lifestyle attempts; others exclude GLP-1 weight-loss drugs from the plan entirely, regardless of medical necessity.
Where Wegovy is covered, cost-sharing and prior authorization renewal requirements — often tied to demonstrated weight loss at set intervals — still apply, and coverage can be tightened or dropped at plan renewal as employers manage the drug class's cost.
That's the general answer. Yours is written in your actual policy.
Drop in your policy or benefits document and get the answer for your exact coverage — with the clause it comes from. Nothing is stored.
Check my policy →